23andMe posts $217M net loss during 'transitional' fiscal year

The consumer genetics company reported full-year revenue came to $272 million, an 11% increase compared with the prior year.

from MobiHealthNews https://ift.tt/4RxwVgd
https://ift.tt/el4YIna